Despite a greater structural genomic instability and a high frequency of TP53 mutations, patients with CK-MDS had less somatic mutations in other MDS-associated genes, and these discrepancies were even more evident in the TP53-mutant subgroup, CK-MDS [97]. Here, TP53 is linked to myelodysplastic syndrome.